472.2EGP
- Active ingredient
- nilutamide
- Strength
- 50 mg
- Form
- tablet
- Manufacturer
- sanofi
- Route
- oral.solid
Uses
Used in the treatment of metastatic prostate cancer as part of androgen deprivation therapy.
Do not use if
Severe hepatic impairment or hypersensitivity to nilutamide.
Side effects
Visual disturbances, hot flushes, nausea, dizziness, or liver abnormalities may occur.
Warnings
Monitor liver function and respiratory symptoms during therapy.
How it works
Nonsteroidal antiandrogen that blocks androgen receptors.
Storage
Store at room temperature.
